CPT 88177Laboratory

Cytp fna eval ea addl

CPT code 88177 covers the laboratory evaluation of cells obtained from a fine needle aspiration (FNA) biopsy for each additional specimen beyond the first. This is an add-on code used when pathologists examine multiple tissue samples from different sites during the same procedure.

Showing rates for

National Average

Base Medicare rate

$28.79

This calculator gives a typical-case estimate using standard Medicare modifier rules. Actual payment depends on payer policies, documentation, code-specific CMS status indicators, and locality. Verify before billing.

RVU breakdown

Work RVU

0.42

PE RVU (NF)

0.46

MP RVU

0.01

Total RVU

0.89

Conversion factor: 32.3465 · Source: CMS MPFS RVU25A · Confidence: High

NCCI bundling edits

Loading bundling edits…

Billing tips

Always bill 88177 with the appropriate primary FNA evaluation code (88172 or 88173) - never bill 88177 as a standalone code
Impact: Prevents automatic denial; 88177 is an add-on code with zero payment when billed alone
Document each specimen with distinct anatomic site or lesion location (e.g., 'right thyroid nodule' vs 'left thyroid nodule', or specific lymph node stations)
Impact: Supports medical necessity for multiple specimens; lack of site-specific documentation causes 30-40% of denials for additional specimens
Bill one unit of 88177 for each additional specimen beyond the first - do not use units to represent multiple slides from the same specimen
Impact: At $28.79 per additional specimen, overbilling units incorrectly risks recoupment; underbilling loses approximately $28.79 per missed specimen
Verify that each specimen was obtained from a separate FNA pass or anatomically distinct site, not simply different slides from the same aspiration
Impact: Medicare defines specimen as material from distinct anatomic site; billing multiple units for same-site samples risks fraud allegations
For specimens from lymph node stations, use specific station numbers (e.g., 2R, 4L, 7) in documentation to support multiple specimen billing
Impact: Station-specific documentation substantiates medical necessity and reduces audit risk, particularly for oncology staging cases
Coordinate with proceduralist to ensure procedure notes clearly document number of separate sites aspirated and match pathology specimen count
Discrepancies between procedure documentation and pathology billing trigger up to 60% of payer audits for 88177

Live Field Datano reports yet

Real billers contribute denial patterns and appeal strategies for this code. Once 5+ reports come in, you’ll see live aggregated data here — the only place this exists, free.

Working with CPT 88177?

Get the free Revenue Protection Toolkit — the denial triggers, modifier pitfalls, and bundling conflicts that quietly cost you reimbursement. Instant download.

Help build the field knowledge

MedPayIQ gets smarter as billers contribute. If you've had this code denied, share what happened so others learn from it. Anonymous, no patient info.

Related actions

Frequently asked questions

What is the Medicare reimbursement rate for CPT code 88177 in 2025?

The 2025 Medicare national average reimbursement for CPT 88177 is $28.79 for both facility and non-facility settings. This is based on a total RVU of 0.89 (0.42 work RVU, 0.46 practice expense RVU, 0.01 malpractice RVU) multiplied by the 2025 conversion factor of 32.3465.

Can CPT 88177 be billed alone or does it require another code?

CPT 88177 cannot be billed alone. It is an add-on code that must be reported with a primary FNA cytopathology evaluation code, either 88172 (immediate cytohistologic study) or 88173 (interpretation and report). Billing 88177 without the primary code will result in automatic denial.

How many times can I bill CPT 88177 for the same patient on the same day?

You can bill 88177 multiple times (multiple units) on the same date of service, with one unit for each additional specimen beyond the first, as long as each specimen represents a distinct anatomic site or lesion. Documentation must clearly identify each separate site sampled to support medical necessity for multiple specimens.

What is the difference between CPT 88172, 88173, and 88177?

CPT 88172 covers immediate cytopathologic study to determine adequacy for diagnosis during the FNA procedure (rapid on-site evaluation). CPT 88173 covers the interpretation and written report of the first FNA specimen. CPT 88177 is an add-on code for each additional specimen beyond the first when multiple sites are aspirated. Bill 88173 for the primary specimen evaluation and 88177 for each additional specimen.

What documentation is required to bill CPT 88177 for multiple specimens?

Required documentation includes: separate specimen labels with distinct anatomic sites (e.g., 'right thyroid nodule,' 'left thyroid nodule'), individual microscopic interpretations for each specimen, written pathology report documenting findings for each site separately, and correlation with the proceduralist's operative note confirming the number of separate anatomic sites aspirated.

Do I need a modifier when billing CPT 88177 for specimens from bilateral sites?

Modifier 59 or XS (separate structure) may be appropriate when billing 88177 for bilateral sites to indicate the specimens are from anatomically distinct structures. This helps prevent bundling denials and clarifies that the additional specimens are medically necessary separate evaluations, not multiple samples from the same lesion.

What is the most common reason for denial of CPT 88177 claims?

The most common denial reason is billing 88177 without the required primary FNA evaluation code (88172 or 88173) on the same claim. The second most common is medical necessity denials when documentation fails to clearly establish that specimens came from anatomically distinct sites rather than multiple passes at the same location.